ATE499110T1 - Aus stammzellen erhaltener parakriner faktor sfrp1 zur verwendung für die verringerung zelltodes im herzgewebe - Google Patents

Aus stammzellen erhaltener parakriner faktor sfrp1 zur verwendung für die verringerung zelltodes im herzgewebe

Info

Publication number
ATE499110T1
ATE499110T1 AT08005943T AT08005943T ATE499110T1 AT E499110 T1 ATE499110 T1 AT E499110T1 AT 08005943 T AT08005943 T AT 08005943T AT 08005943 T AT08005943 T AT 08005943T AT E499110 T1 ATE499110 T1 AT E499110T1
Authority
AT
Austria
Prior art keywords
cell death
factor
paraccrine
sfrp1
stem cells
Prior art date
Application number
AT08005943T
Other languages
English (en)
Inventor
Victor Dzau
Maria Miratsou
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Application granted granted Critical
Publication of ATE499110T1 publication Critical patent/ATE499110T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Psychology (AREA)
  • Physiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
AT08005943T 2005-08-19 2006-08-21 Aus stammzellen erhaltener parakriner faktor sfrp1 zur verwendung für die verringerung zelltodes im herzgewebe ATE499110T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71002805P 2005-08-19 2005-08-19
US71128705P 2005-08-25 2005-08-25

Publications (1)

Publication Number Publication Date
ATE499110T1 true ATE499110T1 (de) 2011-03-15

Family

ID=37758496

Family Applications (2)

Application Number Title Priority Date Filing Date
AT08005943T ATE499110T1 (de) 2005-08-19 2006-08-21 Aus stammzellen erhaltener parakriner faktor sfrp1 zur verwendung für die verringerung zelltodes im herzgewebe
AT06802032T ATE497389T1 (de) 2005-08-19 2006-08-21 Aus stammzellen erhaltener parakriner faktor h12 zur verwendung für die verringerung zelltodes oder für die reparatur von gewebe

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT06802032T ATE497389T1 (de) 2005-08-19 2006-08-21 Aus stammzellen erhaltener parakriner faktor h12 zur verwendung für die verringerung zelltodes oder für die reparatur von gewebe

Country Status (6)

Country Link
US (6) US7638128B2 (de)
EP (4) EP1977758B1 (de)
AT (2) ATE499110T1 (de)
CA (2) CA2619593C (de)
DE (2) DE602006019974D1 (de)
WO (1) WO2007022515A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007055397A1 (en) * 2005-11-08 2007-05-18 Foundation For Biomedical Research And Innovation Method of treatment for ischemic heart disease
GB0707348D0 (en) * 2007-04-17 2007-05-23 Renovo Ltd Medicaments and methods for inhibition of scarring
EP2219661A1 (de) * 2007-11-04 2010-08-25 Duke University Zusammensetzungen zur gewebereparatur/regeneration
US20120156134A1 (en) 2007-12-20 2012-06-21 Shayne Squires Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease
WO2009132815A1 (en) 2008-04-30 2009-11-05 Roche Diagnostics Gmbh Use of sfrp-3 in the assessment of heart failure
GB0818725D0 (en) * 2008-10-13 2008-11-19 Habib Nagy A Pharmaceutical composition
US20120172306A1 (en) * 2009-03-13 2012-07-05 Duke University Use of HASF as a Protective Agent Against Ischemic Tissue Damage
SG10201403202XA (en) * 2009-07-23 2014-08-28 Agency Science Tech & Res Pre-natal mesenchymal stem cells
JP5409222B2 (ja) * 2009-09-10 2014-02-05 学校法人慶應義塾 造血幹細胞の培養方法
US9950016B2 (en) 2011-06-24 2018-04-24 National University Of Ireland, Galway Cell secreted proteins for the treatment of myocardial infarction
WO2013066802A2 (en) * 2011-10-27 2013-05-10 Agency For Science, Technology And Research (A*Star) Compositions and methods for lung regeneration
IN2015DN00934A (de) 2012-08-01 2015-06-12 United Therapeutics Corp
ES2869701T3 (es) 2012-08-01 2021-10-25 United Therapeutics Corp Tratamiento de hipertensión arterial pulmonar con células progenitoras endoteliales tratadas con prostaciclina
AU2014205557B2 (en) 2013-01-09 2017-08-10 United Therapeutics Corporation Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
CN105561338A (zh) * 2015-05-14 2016-05-11 首都医科大学附属北京口腔医院 Sfrp2在促进牙源性间充质干细胞成骨/成牙分化中的应用
DK3344758T3 (da) * 2015-09-01 2021-11-01 Ncardia B V Fremgangsmåde in vitro til differentiering af en human pluripotent stamcellepopulation i en kardiomyocytcellepopulation
WO2018064315A1 (en) * 2016-09-29 2018-04-05 North Carolina State University Stem cell biomimetic microparticles
US11571444B2 (en) 2016-10-24 2023-02-07 United Therapeutics Corporation Enhancement of MSC immunomodulatory properties by treprostinil
EP3801028A4 (de) 2018-05-30 2022-04-13 Direct Biologics LLC Gefrorenes oder pulverförmiges wachstumsfaktor- und extrazelluläre-vesikel-additiv mit einem präparat aus mesenchymalen stammzellen (msc) und verwendungsverfahren
EP3920946A4 (de) 2019-02-07 2022-11-09 Direct Biologics LLC Verfahren zur behandlung von osteoarthritis mit einer kombination ausn mesenchymalen stammzellexosomen, mesenchymalen stammzellen aus der synovia und gerüsten
CA3146433A1 (en) 2019-07-18 2021-01-21 Direct Biologics Llc Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
KR20230004709A (ko) 2020-04-22 2023-01-06 다이렉트 바이오로직스 엘엘씨 감염성 질환과 연관된 염증성 병태를 치료하기 위한 방법 및 조성물
WO2022066714A2 (en) * 2020-09-22 2022-03-31 Children's Medical Center Corporation Delivery of sfrp-3 or foxm1 inhibitor to protect from and treat mitral regurgitation and heart failure
WO2025226276A1 (en) 2024-04-25 2025-10-30 Direct Biologics, Llc Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0932678B2 (de) * 1996-09-24 2010-03-10 Genentech, Inc. Genfamilie von apoptose-verwandten peptiden, dadurch kodierte peptide und verfahren zu deren nutzung
WO2000000610A2 (en) * 1998-06-26 2000-01-06 Incyte Pharmaceuticals, Inc. Human signal peptide-containing proteins
US20030027751A1 (en) * 2001-04-10 2003-02-06 Genvec, Inc. VEGF fusion proteins
CA2456955A1 (en) * 2001-08-09 2003-10-02 Nuvelo, Inc. Novel nucleic acids and secreted polypeptides
WO2003062376A2 (en) * 2002-01-16 2003-07-31 Incyte Genomics, Inc. Molecules for diagnostics and therapeutics
CA2505251A1 (en) * 2002-11-05 2004-05-27 Brigham And Women's Hospital, Inc. Mesenchymal stem cells and methods of use thereof
CA2507581A1 (en) * 2002-12-06 2004-06-24 The Board Of Trustees Of The Leland Stanford Junior University Protection of stem cells from cytotoxic agents by modulation of .beta.-catenin signaling pathways
WO2004087874A2 (en) * 2003-03-28 2004-10-14 Nuvelo, Inc. Novel nucleic acids and polypeptides

Also Published As

Publication number Publication date
WO2007022515A3 (en) 2008-02-28
ATE497389T1 (de) 2011-02-15
US20140296152A1 (en) 2014-10-02
EP2548569A1 (de) 2013-01-23
WO2007022515A2 (en) 2007-02-22
EP1940445A2 (de) 2008-07-09
DE602006020349D1 (de) 2011-04-07
DE602006019974D1 (de) 2011-03-17
US8703710B2 (en) 2014-04-22
US20140357703A1 (en) 2014-12-04
EP2226079A2 (de) 2010-09-08
US20120283183A9 (en) 2012-11-08
US8129344B2 (en) 2012-03-06
EP2226079A3 (de) 2010-12-08
EP1977758A3 (de) 2009-01-07
US20170128526A1 (en) 2017-05-11
EP2226079B1 (de) 2012-07-11
US20080176207A1 (en) 2008-07-24
CA2619593C (en) 2018-12-11
CA2619593A1 (en) 2007-02-22
EP1940445B1 (de) 2011-02-02
CA3022238A1 (en) 2007-02-22
EP1940445A4 (de) 2008-10-15
EP1977758B1 (de) 2011-02-23
US20110003743A1 (en) 2011-01-06
US20070259425A1 (en) 2007-11-08
EP2548569B1 (de) 2014-01-29
US9353168B2 (en) 2016-05-31
US7638128B2 (en) 2009-12-29
WO2007022515A9 (en) 2007-05-10
US9279012B2 (en) 2016-03-08
EP1977758A2 (de) 2008-10-08

Similar Documents

Publication Publication Date Title
DE602006020349D1 (de) AUS STAMMZELLEN ERHALTENER PARAKRINER FAKTOR Sfrp1 ZUR VERWENDUNG FÜR DIE VERRINGERUNG ZELLTODES IM HERZGEWEBE
ATE405644T1 (de) Verfahren zur herstellung und reinigung von erythropoietin
DE502006007198D1 (de) Verfahren zur herstellung von permanenten humanen zelllinien
WO2007079184A3 (en) Co-culture of placental stem cells and stem cells from a second source
PE20090153A1 (es) Metodo para producir una proteina en un cultivo de celulas en base a ph y temperatura reducida
EP2001821A4 (de) Herstellung und verwendung von endophyten als neue inokulationsmittel für die förderung von verbesserter pflanzenwüchsigkeit, -gesundheit, - wachstum, -ertrag, zur verringerung von umweltstress und zur verringerung der abhängigkeit von chemischen pestiziden für die schädlingsbekämpfung
ATE447776T1 (de) Membran-elektrodenbaugruppen für brennstoffzellen,ihre herstellung, verwendung und diese enthaltende brennstoffzellen
WO2004081205A8 (en) Differentiation of human embryonic stem cells to cardiomyocytes
NZ569543A (en) Means and methods for influencing the stability of antibody producing cells
ATE510005T1 (de) Verfahren zur isolierung von zellen aus der nabelschnur
SI2274419T1 (sl) Postopek izdelave lasnih mikromešičkov in novih papil in njihova uporaba za in vitro teste in in vivo implantacijo
WO2008008569A3 (en) Prelamin a pre peptide as a universal stem cell differentiation signal
TW200736399A (en) Expansion and differentiation of neural stem cells under low oxygen conditions
MX2010000747A (es) Metodo para tratar un estado patologico pulmonar en mamiferos, al regular positiva o negativamente los niveles normales in vivo de agentes inflamatorios en celulas de mamifero.
NZ591812A (en) Cell culture method to form aggregates
WO2007016245A3 (en) Reprogramming of adult or neonic stem cells and methods of use
ATE375385T1 (de) Verwendung eines serumfreien zellkulturmediums zur produktion von il-18bp in säugerzellen
DE60233395D1 (de) Die verwendung von abc transporter kodierenden genen zur stimulierung der herstellung von sekundärmetaboliten in biologischen zellen
CR11725A (es) Método para la producción de una enzima lisosomal recombinante humana en endoesperma de cereal
DE502006008908D1 (de) Verwendung von genaktivitäts-klassifikatoren für die in vitro klassifizierung von genexpressionsprofilen von patienten mit infektiösem/nichtinfektiösem multiorganversagen
ATE376427T1 (de) Pharmazeutische zusammensetzungen aus bartflechten (usnea barbata) und johanniskraut (hypericum perforatum) sowie ihre verwendung
Mariano et al. Strain localization due to crack–microcrack interactions: X-FEM for a multifield approach
ATE525642T1 (de) Sensoranordnung und herstellungsverfahren für einen durch kapillareffekt gefüllten diagnose- sensor
ATE483016T1 (de) Biologische materialien und verwendungen davon
WO2010105215A3 (en) Human mast cell line and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties